Transforming pharma R&D with cutting-edge AI.
De-risk pharma R&D by delivering faster and understandable predictions.
Trustworthy, explainable AI for pharma R&D.
Unlock the potential in your pipeline.
Whether you are at the early stages of target identification or advancing through clinical trials, Abzu’s AI-driven insights accelerate and de-risk R&D.
Abzu’s measurable impact in pharma R&D.
Where proven results speak louder than promises, Abzu stands apart.
Abzu’s QLattice uniquely identified key “partner” genes involved in skin spaceflight response, a new discovery for how spaceflight damages skin.
Understanding how bears can hibernate without developing blood clots or muscle atrophy can help humans prepare for the future of space travel.
A strategic partnership with Contera Pharma included ASO and siRNA therapeutic designs and target identification.
Abzu is your partner in disease understanding and drug design.
A cycle of innovation and optimization — to therapeutic realization.
Whether we start with designs or your data, Abzu provides you the insights and confidence to accelerate your R&D and transform concepts into market-ready drugs.
Less data, more discovery.
Make the most out of every piece of information.
Contrary to the data-heavy demands of black-box AI, our technology thrives on minimal data. This efficiency not only accelerates the discovery process, but also reduces your barrier to entry to develop new, innovative drugs.
Abzu is making headlines.
Abzu's innovative work in AI and pharma R&D makes waves in the scientific community and beyond.
Subscribe for
notifications from Abzu.
You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.